Cargando…
F74. CLINICAL SYMPTOMS AND NOT OBJECTIVE COGNITIVE PERFORMANCE DRIVE SUBJECTIVE COGNITIVE COMPLAINTS IN PATIENTS WITH SCHIZOPHRENIA
BACKGROUND: The United States Food and Drug Administration (FDA) recommends that drugs that exert a pro-cognitive effect should be accompanied by measurable improvements in ‘real-world’ functioning. Patients with schizophrenia typically exhibit substantial impairments across a wide range of cognitiv...
Autores principales: | Cotter, Jack, Granger, Kiri, Evenden, John, Barnett, Jennifer, Sand, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888865/ http://dx.doi.org/10.1093/schbul/sby017.605 |
Ejemplares similares
-
S74. EXPLORING PARTICIPANT-LEVEL TRAJECTORIES OF COGNITIVE PERFORMANCE AMONG PATIENTS WITH SCHIZOPHRENIA IN A MULTI-NATIONAL TRIAL
por: Granger, Kiri, et al.
Publicado: (2018) -
The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
por: Cotter, Jack, et al.
Publicado: (2019) -
Subjective cognitive complaints and relations to objective cognitive performance among Lebanese patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2021) -
T79. AFFECTIVE FACE PROCESSING IN SCHIZOPHRENIA: DISORDER-SPECIFIC OR TRANSDIAGNOSTIC DEFICIT?
por: Cotter, Jack, et al.
Publicado: (2018) -
Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson's Disease
por: Hong, Jin Yong, et al.
Publicado: (2018)